BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6483959)

  • 1. Selectivity of cholestyramine treatment on hepatic mixed function oxidase activity.
    Bachmann K; Schwartz J; Forney R; Sherman G; Jauregui L
    Pharmacology; 1984; 29(3):128-41. PubMed ID: 6483959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of calcitonin on hepatic drug metabolism.
    Godinho AF; Cavalcante GJ; Machado MG; Faria TF; Gil TC; Coutinho RB; Garcia C
    Braz J Med Biol Res; 1988; 21(4):851-3. PubMed ID: 3240382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The B-vitamin group and the activity of hepatic microsomal mixed-function oxidases of the growing Wistar rat.
    Miltenberger R; Oltersdorf U
    Br J Nutr; 1978 Jan; 39(1):127-37. PubMed ID: 619964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of drug metabolism by the antimalarial drugs chloroquine and primaquine in the rat.
    Back DJ; Purba HS; Staiger C; Orme ML; Breckenridge AM
    Biochem Pharmacol; 1983 Jan; 32(2):257-63. PubMed ID: 6870955
    [No Abstract]   [Full Text] [Related]  

  • 5. Interaction between antipyrine and aminopyrine.
    Vesell ES; Passananti GT; Hepner GW
    Clin Pharmacol Ther; 1976 Dec; 20(6):661-9. PubMed ID: 991537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of mixed function oxidases in rat liver by trans- and cis-1,2-dichloroethylene.
    Freundt KJ; Macholz J
    Toxicology; 1978 Jun; 10(2):131-9. PubMed ID: 684758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical changes provoked in rat liver by cholestatic doses of -naphthylisothiocyanate.
    Buxton BH; Witschi H; Plaa GL
    Toxicol Appl Pharmacol; 1973 Jan; 24(1):60-72. PubMed ID: 4686786
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of ozone on drug-induced sleeping time in mice pretreated with mixed-function oxidase inducers and inhibitors.
    Graham JA; Menzel DB; Miller FJ; Illing JW; Gardner DE
    Toxicol Appl Pharmacol; 1982 Mar; 62(3):489-97. PubMed ID: 7071864
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of perfluorodecanoic acid on hepatic stearoyl-coenzyme A desaturase and mixed function oxidase activities in rats.
    Van Rafelghem MJ; Andersen ME
    Fundam Appl Toxicol; 1988 Oct; 11(3):503-10. PubMed ID: 2906022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cimetidine or ranitidine pretreatment on hepatic mixed function oxidase activity in the rat.
    Yee NS; Shargel L
    Drug Metab Dispos; 1986; 14(5):580-4. PubMed ID: 2876865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of beryllium chloride on rat liver microsomal enzymes.
    Teixeira CF; Yasaka WJ; Silva LF; Oshiro TT; Oga S
    Toxicology; 1990 Apr; 61(3):293-301. PubMed ID: 2109906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of acute and repeated chlordimeform treatment on rat hepatic microsomal drug metabolizing enzymes.
    Budris DM; Yim GK; Schnell RC
    J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):175-82. PubMed ID: 6440975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pregnenolone carbonitrile, promethazine and antipyrine pretreatment on antipyrine metabolite formation in rats.
    Shaw PN; Hall ST; Houston JB
    Xenobiotica; 1986 Dec; 16(12):1109-16. PubMed ID: 3798958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonidine effects on disposition of xenobiotics in rats: inhibited elimination of flow-limited but not extraction-limited agents.
    Ben-Zvi Z; Hurwitz A
    Br J Pharmacol; 1988 May; 94(1):97-102. PubMed ID: 3401645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibition and potentiation of procarbazine on hepatic mixed-function oxidases in phenobarbital tolerant and nontolerant mice.
    Onoda K; Ho IK
    Drug Chem Toxicol; 1980; 3(2):185-200. PubMed ID: 7227217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on the combination of drugs. V. Effect of 4-hydroxyantipyrine on the metabolism of amobarbital and pentobarbital].
    Niwa H; Nakayama T
    Yakugaku Zasshi; 1968 Jul; 88(7):843-6. PubMed ID: 5750524
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug tolerance and detoxicating enzymes in Octodon degus and Wistar rats. A comparative study.
    Letelier ME; Del Villar E; Sanchez E
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985; 80(1):195-8. PubMed ID: 2858344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased sleeping time after pentobarbital anesthesia in rats treated with intravenous injection of BCG.
    Pereira FE; Motta L; Cardoso A
    Arq Gastroenterol; 1999; 36(3):159-64. PubMed ID: 10751904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms in the potentiation and inhibition of pharmacological actions of hexobarbital and zoxazolamine by glycofurol.
    Yasaka WJ; Sasame HA; Saul W; Maling HM; Gillette JR
    Biochem Pharmacol; 1978; 27(24):2851-8. PubMed ID: 736977
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative metabolism of benzo[a]pyrene and drugs in human liver.
    Kapitulnik J; Popper PJ; Conney AH
    Clin Pharmacol Ther; 1977 Feb; 21(2):166-76. PubMed ID: 837635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.